LEMAITRE VASCULAR INC's ticker is LMAT and the CUSIP is 525558201. A total of 112 filers reported holding LEMAITRE VASCULAR INC in Q4 2016. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,776 | +644.2% | 50,950 | +818.0% | 0.13% | +718.8% |
| Q2 2023 | $373 | -99.9% | 5,550 | -27.4% | 0.02% | -30.4% |
| Q1 2022 | $355,000 | -61.5% | 7,645 | -70.2% | 0.02% | -91.6% |
| Q4 2019 | $922,000 | -24.2% | 25,649 | -27.9% | 0.28% | -39.3% |
| Q3 2019 | $1,216,000 | +156.0% | 35,582 | +109.6% | 0.45% | +157.4% |
| Q2 2019 | $475,000 | -54.4% | 16,979 | -36.9% | 0.18% | -21.8% |
| Q3 2018 | $1,042,000 | +3.1% | 26,894 | -11.0% | 0.22% | +7.1% |
| Q2 2018 | $1,011,000 | -67.8% | 30,209 | -65.1% | 0.21% | -65.5% |
| Q1 2018 | $3,140,000 | +13.5% | 86,675 | -0.2% | 0.61% | -6.9% |
| Q4 2017 | $2,766,000 | -13.2% | 86,858 | +2.0% | 0.65% | -10.4% |
| Q3 2017 | $3,188,000 | -3.0% | 85,185 | -19.1% | 0.73% | -21.0% |
| Q2 2017 | $3,288,000 | +115.0% | 105,322 | +69.7% | 0.92% | +123.5% |
| Q1 2017 | $1,529,000 | +88.5% | 62,062 | +93.9% | 0.41% | +78.0% |
| Q4 2016 | $811,000 | – | 32,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 350,194 | $11,724,000 | 1.96% |
| Ranger Investment Management | 699,843 | $23,431,000 | 1.64% |
| THB ASSET MANAGEMENT | 392,100 | $13,127,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 64,550 | $2,161,000 | 1.55% |
| Conestoga Capital Advisors, LLC | 1,392,591 | $46,624,000 | 1.50% |
| Summit Creek Advisors LLC | 213,761 | $7,157,000 | 1.28% |
| Biondo Investment Advisors, LLC | 107,405 | $3,603,000 | 0.91% |
| Concorde Asset Management, LLC | 21,207 | $710,000 | 0.81% |
| Capital Impact Advisors, LLC | 51,542 | $1,739,000 | 0.64% |
| Sapphire Star Partners LP | 12,290 | $412,000 | 0.42% |